Amy Eskin is a trial lawyer who has been successfully representing injured consumers nationally in personal injury, medical negligence, products liability and complex pharmaceutical and medical device cases for more than 25 years.
She is a tenacious, highly accessible and personal advocate for her clients and is devoted to representing individuals who have been injured by corporations who value profits over safety. Amy loves trying cases in order to obtain justice for those who have been injured.
In April of 2013, Amy was honored to be awarded the Civil Justice Award by the San Francisco Trial Lawyer’s Association – an award to an attorney who “fights the good fight in the trenches every day” and who “contributes to the betterment of consumers and/or injured victim and their families.”
In July of 2016, Amy was appointed as Plaintiff’s Liaison Counsel by Judge Mary Wiss in JCCP 4863 In Re Pradaxa cases. Also in July 2016, Amy was elected as a Co-Chair of the American Association of Justice’s (AAJ) Transvaginal Mesh Litigation Group.
Amy has been appointed to the Plaintiffs’ Steering Committee by the Honorable Dennis Saylor In Re: Zofran (Ondansetron) Products Liability Litigation. Amy will take a leadership position in advocating for the parents and child victims of birth defects from Zofran and Ondansetron – heart defects, cleft palate defects and other congenital birth defects.
Ms. Eskin has been litigating transvaginal mesh cases since 2008. In April of 2012, Chief U.S. District Justice Joseph R. Goodwin appointed Amy as co-lead counsel of MDL 2325 In Re American Medical Systems, Inc. Pelvic Repair System Products Liability Litigation where she directs the prosecution of over 7,500 cases filed on behalf of women who suffered devastating injuries as a result of being implanted with transvaginal mesh products manufactured by American Medical Systems. Amy is also one of only 8 attorneys appointed by Judge Goodwin to serve on the Executive Committee overseeing thousands of lawsuits filed by injured women against American Medical Systems, Boston Scientific, Ethicon/Gynecare (Johnson & Johnson) and Coloplast which have been centralized in the U.S. District Court for the Southern District of West Virginia. Amy plays a central role in advocating for these victims of corporate misconduct.
Amy has worked extensively on pharmaceutical and medical device litigation including, Breast Implants, DES, Fen-Phen, Sulzer-Hip Implants. For more than a decade she dedicated much of her time to representing clients who had been injured by the diet drug combination Fen/Phen and for whom she has recovered over $150,000,00.00. She served as a member of the Law and Briefing Committee in In Re Zypexa Product Liability Litigation (MDL 1956).
She has authored a number of articles in legal publications and has lectured extensively to lawyers, health care professionals, law students and paralegals on many topics, including ethics, discovery and trial practice.
In December 2010, Amy was featured in Plaintiff Magazine and lauded for her fierce determination in taking on “big pharma and other giants.” In 2011, San Francisco Attorney Magazine recognized her commitment to ensuring access to trial by jury for her clients.